Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Ryerson University

$25,000.00

In-vivo glucoCEST MRI - The future of organ metabolic imaging

EF 2018-19

Résumé
Imaging of fetal metabolism is currently unavailable but its development is key to understanding fetal*development and physiology. Since glucose is the primary source of energy for the fetus, being able to image*its uptake and utilization by the fetal organs could reveal new information about fetal organ growth and*function.*In the proposed study, the industry partner would like to develop a non-invasive imaging technique that traces*glucose metabolism by the different fetal organs. The technique pivots on magnetic resonance imaging (MRI),*which has no harmful radiation and is considered safe for the mother and the fetus. The industry partner has*started developing this technique, yet it is currently still an unusable product. In the proposed collaboration we*will work on further developing this technique in order to turn it into a usable, marketable imaging product.*We will carry out analysis, computer simulation, optimization, and testing of the currently available industry*product, thereby improving its capabilities and utility in fetal imaging. The resulting improved and marketable*product will address a current technical gap in fetal imaging whiles satisfying a growing need for non-invasive*means of imaging metabolic processes. The successful completion of this project will bring tremendous value*to Siemens as it pushes the boundaries of fetal imaging in terms of technical capabilities, allowing new*techniques to build on it while facilitating new scientific avenues in understanding maternal-fetal physiology in*Canada and internationally.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
531292-2018
Name nom
Sussman, Dafna
Department département
Electrical, Computer and Biomedical Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
In-vivo glucoCEST MRI - The future of organ metabolic imaging
Keyword
NSERC
Application summary
Imaging of fetal metabolism is currently unavailable but its development is key to understanding fetal*development and physiology. Since glucose is the primary source of energy for the fetus, being able to image*its uptake and utilization by the fetal organs could reveal new information about fetal organ growth and*function.*In the proposed study, the industry partner would like to develop a non-invasive imaging technique that traces*glucose metabolism by the different fetal organs. The technique pivots on magnetic resonance imaging (MRI),*which has no harmful radiation and is considered safe for the mother and the fetus. The industry partner has*started developing this technique, yet it is currently still an unusable product. In the proposed collaboration we*will work on further developing this technique in order to turn it into a usable, marketable imaging product.*We will carry out analysis, computer simulation, optimization, and testing of the currently available industry*product, thereby improving its capabilities and utility in fetal imaging. The resulting improved and marketable*product will address a current technical gap in fetal imaging whiles satisfying a growing need for non-invasive*means of imaging metabolic processes. The successful completion of this project will bring tremendous value*to Siemens as it pushes the boundaries of fetal imaging in terms of technical capabilities, allowing new*techniques to build on it while facilitating new scientific avenues in understanding maternal-fetal physiology in*Canada and internationally.